<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03842592</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A03328-47</org_study_id>
    <nct_id>NCT03842592</nct_id>
  </id_info>
  <brief_title>Ventricular Arrhythmia After Myocarditis in Sportsman</brief_title>
  <acronym>ARYMYS</acronym>
  <official_title>Quantification of Ventricular Arrhythmia After Myocarditis in Sportsman</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to assess the prevalence of ventricular rhythmic disorder after an acute
      myocarditis in sportsmen.

      50 patients with acute myocarditis, confirmed by MRI, will be assessed by ECG Holter and
      Treadmill stress test during a 1-year follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complex ventricular arrhythmia</measure>
    <time_frame>any timepoint: 3 month and/or 1 year</time_frame>
    <description>any ventricular tachycardia (triplet or more), ventricular fibrillation (observed on ECG Holter or during stress test)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In-hospital ventricular arrhythmia</measure>
    <time_frame>up to 2 weeks after admission</time_frame>
    <description>any ventricular tachycardia (triplet or more), ventricular fibrillation, recorded on ECG monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular remodeling</measure>
    <time_frame>between baseline and 3 months</time_frame>
    <description>Change in LV volumes during time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular fibrosis</measure>
    <time_frame>between baseline and 3 months</time_frame>
    <description>Change in interstitial fibrosis by T1 mapping cardiac magnetic resonnance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardio vascular event</measure>
    <time_frame>up to 2 years after inclusion</time_frame>
    <description>CV death, sudden cardiac death, cardiac graft or haemodynamic support, hospitalisation for heart failure, new event of myocarditis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>return to physical activity</measure>
    <time_frame>up to 2 years after inclusion</time_frame>
    <description>defined as at least 75% of exercising time (in hours per week)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Myocarditis Acute</condition>
  <condition>Ventricular Arrythmia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Treadmill Stress test</intervention_name>
    <description>Ventricular arrhythmia will be assessed by ECG Holter and during treadmill stress test, both being performed 3 months and 1 year after acute myocarditis</description>
    <other_name>ECG Holter</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute myocarditis, diagnosed on the association of (a) recent viral infection (upper
             airway, gastro-intestinal) , (b) troponin increase, and (c) chest pain AND myocarditis
             confirmed by cardiac magnetic resonance 2 out of 3 Lake Louise criteria, either T2
             hypersignal, early enhancement or late gadolinium enhancement.

          -  regular physical activity, recreational or competitive: &gt;=4 hours weekly

          -  written informed consent

        Exclusion Criteria:

          -  coronary artery disease

          -  acute inflammatory cardiomyopathy (sarcoidosis, fulminant myocarditis, Tako Tsubo,
             eosinophilic myocarditis, Lyme disease)

          -  history of myocarditis

          -  contra-indication to cardiac MRI

          -  patient unable to perform a treadmill stress test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loïc BIERE, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiology, University Hospital of Angers (France)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Loïc BIERE, MD PhD</last_name>
    <phone>+33 241354854</phone>
    <email>lobiere@chu-angers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fabrice PRUNIER, MD PhD</last_name>
    <phone>+33 241354858</phone>
  </overall_contact_backup>
  <reference>
    <citation>Te ALD, Wu TC, Lin YJ, Chen YY, Chung FP, Chang SL, Lo LW, Hu YF, Tuan TC, Chao TF, Liao JN, Chien KL, Lin CY, Chang YT, Chen SA. Increased risk of ventricular tachycardia and cardiovascular death in patients with myocarditis during the long-term follow-up: A national representative cohort from the National Health Insurance Research Database. Medicine (Baltimore). 2017 May;96(18):e6633. doi: 10.1097/MD.0000000000006633.</citation>
    <PMID>28471960</PMID>
  </reference>
  <reference>
    <citation>Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009 Mar 3;119(8):1085-92. doi: 10.1161/CIRCULATIONAHA.108.804617. Epub 2009 Feb 16.</citation>
    <PMID>19221222</PMID>
  </reference>
  <reference>
    <citation>Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA 3rd, Cooper LT Jr, Link MS, Maron MS; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 1;132(22):e273-80. doi: 10.1161/CIR.0000000000000239. Epub 2015 Nov 2. Review.</citation>
    <PMID>26621644</PMID>
  </reference>
  <reference>
    <citation>Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87. doi: 10.1016/j.jacc.2009.02.007.</citation>
    <PMID>19389557</PMID>
  </reference>
  <reference>
    <citation>Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht210. Epub 2013 Jul 3.</citation>
    <PMID>23824828</PMID>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>January 28, 2019</study_first_submitted>
  <study_first_submitted_qc>February 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>February 12, 2019</last_update_submitted>
  <last_update_submitted_qc>February 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Myocarditis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

